The Short-term Verbal Memory Endophenotype for Developmental Language Disorder Language Disorder
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age5-10
SponsorFather Flanagan's Boys' Home
About this trial
The goal of this clinical trial is to determine how memory and attention affect the ability of children with developmental language disorder (DLD) to learn and use new vocabulary.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Has DLD or typical language development
Disqualifiers
Has not been exposed to English since birth
Has other neurodevelopmental or sensory condition that could explain the language problem (e.g., intellectual disability, autism, hearing loss).
Trial design
Design model
Parallel
Treatments tested in this trial
Supportive learning
BehavioralAll interventions are manipulations to the stimuli that the child hears with the goal of discovering which manipulations support verbal learning.
Cascades
BehavioralThe intervention is a manipulation of word instruction with the goal of discovering whether weaker word learning results in cascading effects on semantic category memory and sentence comprehension.
Treatment groups
120 Participants
are divided into 5 treatment groupsGroup A: ProsodyExperimental treatment 1 intervention
Group B: MeaningExperimental treatment 1 intervention
Group C: GrammarExperimental treatment 1 intervention
Group D: AttentionExperimental treatment 1 intervention
Group E: EncodingExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Accuracy of Syllable Repetition
Number of syllables pronounced correctly.
Time frame
Day 12
Accuracy of Word Comprehension
Number of correct answers on a 4-alternative-forced-choice word comprehension probe.
Time frame
Day 2Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Father Flanagan's Boys' Home
Lead sponsor
University of Iowa
Collaborator
National Institutes of Health (NIH)
Collaborator
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator
Source ClinicalTrials.gov